Prostate Cancer - Results from #80

NXP800 activates the unfolded protein response, altering AR and E2F function to impact castration-resistant prostate cancer growth. January 13, 2025

Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study. January 13, 2025

Contemporary prostate cancer radiation therapy trials may underestimate the risk of biochemical recurrence. January 13, 2025

Novel hormonal agents in men with metastatic castration resistant prostate cancer and reduced performance status: Experiences of a specialized single center. January 10, 2025

Physician Payment Incentives and Active Surveillance in Low-Risk Prostate Cancer. January 10, 2025

Ascertaining provider-level implicit bias in electronic health records with rules-based natural language processing: A pilot study in the case of prostate cancer. January 10, 2025

Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancer. January 10, 2025

Time to Castration Resistance is Associated With Overall Survival Even After the Achievement of Castration Resistance in Metastatic Prostate Cancer. January 10, 2025

Impact of Intraoperative Opioid Use and a Combined Anesthesia Regimen in Patients Undergoing Radical Prostatectomy for Prostate Cancer in a Single-Center Cohort. January 9, 2025

Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients. January 9, 2025

Molecular Detection of Lymph Node Metastases with One-Step Nucleic Acid Amplification (OSNA) Pooling in Prostate Cancer: The POPCORN Study. January 9, 2025

The Effect of Resistance and/or Aerobic Training on Quality of Life, Fitness, and Body Composition in Prostate Cancer Patients-A Systematic Review and Meta-Analysis. January 9, 2025

Current Clinical Applications of PSMA-PET for Prostate Cancer Diagnosis, Staging, and Treatment. January 9, 2025

Enhancing Data Completeness in Early Detection Pathway of Prostate Cancer: Integration of a Dashboard-Driven Feedback Tool to Improve Quality of Care. January 9, 2025

Prostate Cancer Risk Prediction Model Using Clinical and Magnetic Resonance Imaging-Related Findings: Impact of Combining Lesions' Locations and Apparent Diffusion Coefficient Values. January 8, 2025

Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta-analysis. January 8, 2025

Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer. January 8, 2025

Clinical Feasibility of 3-D Acoustic Radiation Force Impulse (ARFI) Imaging for Targeted Prostate Biopsy Guidance. January 8, 2025

Prostate MRI and clinicopathologic risk calculator to predict laterality of extraprostatic extension at radical prostatectomy. January 8, 2025

Rates of PSMA PET Staging and Positivity in Newly Diagnosed Prostate Cancer in a National Health Care System. January 7, 2025

Page 5 of 1455